Article Details

Nectin Therapeutics Enters Clinical Stage With Drug for Non-Responders to Checkpoint Inhibitors

Retrieved on: 2022-12-01 21:45:08

Tags for this article:

Click the tags to see associated articles and topics

Nectin Therapeutics Enters Clinical Stage With Drug for Non-Responders to Checkpoint Inhibitors. View article details on HISWAI: https://www.precisiononcologynews.com/drug-discovery-development/nectin-therapeutics-enters-clinical-stage-drug-non-responders-checkpoint

Excerpt

The first-in-human trial of NTX1088, a monoclonal antibody, will test its activity in patients who miss out on anti-PD-1 immunotherapy benefit.

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up